BCL2 and Parkinson disease: One study indicated that down-regulating the expression of the pro-apoptotic factor Bax and reducing the Bax/Bcl-2 ratio effectively mitigated degenerative lesions in dopaminergic neurons associated with PD (Yang et al., 2025).